Florent Le Prado's areas of practice include venture capital, private equity, M&A, and capital markets.
He primarily represents high-growth listed and unlisted companies, their managers, and the private equity and industrial investors that finance them at every stage of development from entrepreneurial start-ups to global corporations.
Florent's recent experience includes representing technology and life sciences companies, including Welcome to the Jungle, Ivalua, Adikteev, SuperSonic Imagine, TxCell, Pharnext, Inside Secure, Diaxonhit, Alizé Pharma, and Cellectis. His recent investor-side representations include Alven Capital Partners, Bpifrance Investissement, Creadev (Mulliez family), Ring Capital, Idinvest Partners, Elaia Partners, and Seventure Partners.
Illustrative transactions in which Florent has advised include the tender offers on SuperSonic Imagine, Coheris, and TxCell; the IPOs of Medincell and Pharnext; the LBO of Brico Privé by Florac; the latest financing rounds of Welcome to the Jungle, Ivalua, Foodles, Malt, InnovaFeed, Linkfluence, Actility, and Younited Credit; the acquisition of Elium by eMoteev (Adikteev Group); the sale of Alizé Pharma to Millendo Therapeutics; and the issue of convertible bonds (Oceanes) by Inside Secure.
- ESSEC Business School (M.Sc. in Management 2014); Paris Bar School (CAPA 2013); University of Paris II-Panthéon Assas (Master 2 in Business Law 2010)
- Gold Trophy in Venture Capital & Capital Development at the 2017 Trophées du Droit ceremony for the 7th time in a row (biennially since 2005) — Décideurs Magazine, Paris
- French and English